Anúncio
Anúncio

OKUR

OKUR logo

OnKure Therapeutics, Inc. Class A Common Stock

2.85
USD
Patrocinado
+0.07
+2.52%
07 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

2.81

-0.04
-1.40%

Relatórios de Lucros OKUR

Rácio de surpresa positiva

OKUR separação 11 de 19 últimas estimativas.

58%

Próximo Relatório

Data do Próximo Relatório
09 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$1.17
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
+7.34%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
-14.60%

OnKure Therapeutics, Inc. Class A Common Stock earnings per share and revenue

On 06 de nov. de 2025, OKUR reported earnings of -1.09 USD per share (EPS) for Q3 25, beating the estimate of -1.22 USD, resulting in a 10.80% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -6.96% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 analistas forecast an EPS of -1.17 USD, with revenue projected to reach -- USD, implying an aumentar of 7.34% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
For Q3 2025, OnKure Therapeutics, Inc. Class A Common Stock reported EPS of -$1.09, beating estimates by 10.8%, and revenue of $0.00, 0% as expectations.
The stock price moved down -6.96%, changed from $3.16 before the earnings release to $2.94 the day after.
The next earning report is scheduled for 09 de mar. de 2026.
Based on 7 analistas, OnKure Therapeutics, Inc. Class A Common Stock is expected to report EPS of -$1.17 and revenue of -- for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio